2010 Health

Topics also related to Technology:

Photo

FDA seen tougher on drug risks post-Avandia

NEW YORK - Regulators appear to be increasing their scrutiny of product risks after cases like the bitter debate over the diabetes pill Avandia, industry executives and experts said this week.

Analysis: Sluggish medical device sector ripe for mergers

NEW YORK - The stage is set for more dealmaking in the medical device sector, with companies eager to find faster growth amid a stubbornly weak economy and potential targets still attractively valued.

Photo

AstraZeneca CEO wary of U.S. FDA budget cuts

NEW YORK - Sharp cuts in taxpayer funding for the U.S. Food and Drug Administration could hurt pharmaceutical companies that want faster reviews of their products, AstraZeneca Plc's chief executive said on Wednesday.

Photo

Analysis: Health insurers shake up model after U.S. overhaul

NEW YORK - Become tech-savvy. Bulk up. Venture abroad.

Health overhaul should press ahead: industry

NEW YORK - Repeal reform? No thanks, say health insurers, drugmakers and others looking for a clearer picture of the U.S. healthcare market after the bruising passage of the controversial overhaul law.

Analysis: Drug industry doses up on emerging markets

NEW YORK - Big Pharma's drive into emerging markets could make drugmakers look a lot more like consumer goods companies in future. That may be no bad thing.

Photo

Analysis: Americans make slow return to doctor's offices

NEW YORK - Americans are slowly making their way back to the doctor's office after many months of skimping on medical care, holding off on everything from routine visits to hip replacements.

Photo

New Aetna CEO brings style shift to insurer

NEW YORK - Aetna Inc President Mark Bertolini, who becomes CEO later this month, has half the kidneys and twice the energy of an ordinary human being and is set to take on the Herculean task of trying to change the health insurance industry's villainous image. | Video

Photo

Health Summit quotes of the day

Following is a selection of quotes from the Reuters Health Summit: | Video

Photo

Analysis: Top-name drug recalls a bitter pill for consumers

NEW YORK - With bugs in baby formula, glass flakes in intravenous drugs and foul odors emanating from Lipitor and children's Tylenol, a steady stream of high profile product recalls is undermining confidence in top drugmakers.

Analysis: Genzyme seen an anomaly in bite-sized market

NEW YORK - Sanofi-Aventis' $18.5 billion pursuit of Genzyme Corp may be a foregone conclusion for many healthcare industry executives and bankers, but few rivals likely will copy the hostile bid.

Speakers

Summit Date Category
Financial Regulation 2014 Apr 28 - May 1 Financial Services/Exchanges
Cybersecurity 2014 May 12 - 14 Financial Services/Exchanges
Japan Investment 2014 May 19 - 21 Financial Services/Exchanges
Global Wealth Management 2014 Jun 16 - 18 Financial Services/Exchanges
Aerospace and Defense 2014 Sep 8 - 11 Aerospace/Defense
Russia Investment 2014 Sep 22 - 24 Financial Services/Exchanges
Eastern Europe Investment 2014 Sep 29 - Oct 1 Financial Services / Exchanges
Middle East Investment 2014 Oct 20 - 23 Financial Services/Exchanges
China 2014 Oct 27 - 29 Financial Services / Exchanges
Global Commodities and Resources 2014 Nov 3 - 5 Financial Services/Exchanges
Global Investment Outlook 2014 Nov 17 - 20 Financial Services/Exchanges

Topics also related to Technology: